Product Details for NDA 017533
KLONOPIN (CLONAZEPAM)
0.5MG
Marketing Status: Prescription
1MG
Marketing Status: Prescription
2MG
Marketing Status: Prescription
0.125MG
Marketing Status: Discontinued
0.25MG
Marketing Status: Discontinued
0.5MG
Marketing Status: Prescription
Active Ingredient: CLONAZEPAM
Proprietary Name: KLONOPIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.5MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N017533
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: CHEPLAPHARM ARZNEIMITTEL GMBH
Marketing Status: Prescription
Patent and Exclusivity Information
KLONOPIN (CLONAZEPAM)
Proprietary Name: KLONOPIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.5MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N017533
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: CHEPLAPHARM ARZNEIMITTEL GMBH
Marketing Status: Prescription
Patent and Exclusivity Information
1MG
Marketing Status: Prescription
Active Ingredient: CLONAZEPAM
Proprietary Name: KLONOPIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N017533
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: CHEPLAPHARM ARZNEIMITTEL GMBH
Marketing Status: Prescription
Patent and Exclusivity Information
KLONOPIN (CLONAZEPAM)
Proprietary Name: KLONOPIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N017533
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: CHEPLAPHARM ARZNEIMITTEL GMBH
Marketing Status: Prescription
Patent and Exclusivity Information
2MG
Marketing Status: Prescription
Active Ingredient: CLONAZEPAM
Proprietary Name: KLONOPIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N017533
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: CHEPLAPHARM ARZNEIMITTEL GMBH
Marketing Status: Prescription
Patent and Exclusivity Information
KLONOPIN (CLONAZEPAM)
Proprietary Name: KLONOPIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N017533
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: CHEPLAPHARM ARZNEIMITTEL GMBH
Marketing Status: Prescription
Patent and Exclusivity Information
0.125MG
Marketing Status: Discontinued
Active Ingredient: CLONAZEPAM
Proprietary Name: KLONOPIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.125MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017533
Product Number: 005
Approval Date: Apr 9, 1997
Applicant Holder Full Name: CHEPLAPHARM ARZNEIMITTEL GMBH
Marketing Status: Discontinued
Patent and Exclusivity Information
KLONOPIN (CLONAZEPAM)
Proprietary Name: KLONOPIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.125MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017533
Product Number: 005
Approval Date: Apr 9, 1997
Applicant Holder Full Name: CHEPLAPHARM ARZNEIMITTEL GMBH
Marketing Status: Discontinued
Patent and Exclusivity Information
0.25MG
Marketing Status: Discontinued
Active Ingredient: CLONAZEPAM
Proprietary Name: KLONOPIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.25MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017533
Product Number: 006
Approval Date: Apr 9, 1997
Applicant Holder Full Name: CHEPLAPHARM ARZNEIMITTEL GMBH
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: KLONOPIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.25MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N017533
Product Number: 006
Approval Date: Apr 9, 1997
Applicant Holder Full Name: CHEPLAPHARM ARZNEIMITTEL GMBH
Marketing Status: Discontinued
Patent and Exclusivity Information